PTC Therapeutics's total inventories for the quarter that ended in Mar. 2022 was $15.3 Mil. PTC Therapeutics's average total inventories from the quarter that ended in Dec. 2021 to the quarter that ended in Mar. 2022 was $15.6 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. PTC Therapeutics's Net-Net Working Capital per share for the quarter that ended in Mar. 2022 was $-16.66.
Inventory can be measured by days sales of inventory (DSI).
PTC Therapeutics's days sales of inventory (DSI) for the
three
months ended in Mar. 2022 was 9.55.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PTC Therapeutics's Days Inventory for the
three
months ended in Mar. 2022 was 140.17.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PTC Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2022 was 0.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.10.
PTC Therapeutics Total Inventories Historical Data
The historical data trend for PTC Therapeutics's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
PTC Therapeutics Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Total Inventories
10.75
16.12
19.29
18.70
15.86
PTC Therapeutics Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Total Inventories
16.23
16.44
15.61
15.86
15.28
PTC Therapeutics Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
PTC Therapeutics (NAS:PTCT) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
PTC Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is
5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PTC Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
PTC Therapeutics Total Inventories Related Terms
Thank you for viewing the detailed overview of PTC Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.79(4.47%) Volume: 512,546 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:PTCT has been successfully added to your 
